Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets
Display Omitted
Gespeichert in:
| Autor*in: |
Salazar, Jaime [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
13 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms - Heyden, Mariano L.M. ELSEVIER, 2022, official journal of the European Federation for Pharmaceutical Sciences, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:49 ; year:2013 ; number:4 ; day:16 ; month:07 ; pages:565-577 ; extent:13 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ejps.2013.04.003 |
|---|
| Katalog-ID: |
ELV033288569 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV033288569 | ||
| 003 | DE-627 | ||
| 005 | 20230623225238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejps.2013.04.003 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013015000008.pica |
| 035 | |a (DE-627)ELV033288569 | ||
| 035 | |a (ELSEVIER)S0928-0987(13)00130-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 300 |a 330 |a 360 |q VZ |
| 084 | |a 85.05 |2 bkl | ||
| 084 | |a 85.06 |2 bkl | ||
| 084 | |a 89.52 |2 bkl | ||
| 100 | 1 | |a Salazar, Jaime |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets |
| 264 | 1 | |c 2013 | |
| 300 | |a 13 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Poorly soluble drugs |2 Elsevier | |
| 650 | 7 | |a Particle size reduction |2 Elsevier | |
| 650 | 7 | |a High pressure homogenization |2 Elsevier | |
| 650 | 7 | |a Spray-drying |2 Elsevier | |
| 650 | 7 | |a Tableting |2 Elsevier | |
| 650 | 7 | |a Drug nanocrystals |2 Elsevier | |
| 700 | 1 | |a Müller, Rainer H. |4 oth | |
| 700 | 1 | |a Möschwitzer, Jan P. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Heyden, Mariano L.M. ELSEVIER |t The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms |d 2022 |d official journal of the European Federation for Pharmaceutical Sciences |g New York, NY [u.a.] |w (DE-627)ELV009954198 |
| 773 | 1 | 8 | |g volume:49 |g year:2013 |g number:4 |g day:16 |g month:07 |g pages:565-577 |g extent:13 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejps.2013.04.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 85.05 |j Betriebssoziologie |j Betriebspsychologie |q VZ |
| 936 | b | k | |a 85.06 |j Unternehmensführung |q VZ |
| 936 | b | k | |a 89.52 |j Politische Psychologie |j Politische Soziologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 49 |j 2013 |e 4 |b 16 |c 0716 |h 565-577 |g 13 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
j s js |
|---|---|
| matchkey_str |
salazarjaimemllerrainerhmschwitzerjanp:2013----:plctooteobntvprilszrdcinehooy4tpoueatis |
| hierarchy_sort_str |
2013 |
| bklnumber |
85.05 85.06 89.52 |
| publishDate |
2013 |
| allfields |
10.1016/j.ejps.2013.04.003 doi GBVA2013015000008.pica (DE-627)ELV033288569 (ELSEVIER)S0928-0987(13)00130-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 300 330 360 VZ 85.05 bkl 85.06 bkl 89.52 bkl Salazar, Jaime verfasserin aut Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets 2013 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals Elsevier Müller, Rainer H. oth Möschwitzer, Jan P. oth Enthalten in Elsevier Heyden, Mariano L.M. ELSEVIER The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms 2022 official journal of the European Federation for Pharmaceutical Sciences New York, NY [u.a.] (DE-627)ELV009954198 volume:49 year:2013 number:4 day:16 month:07 pages:565-577 extent:13 https://doi.org/10.1016/j.ejps.2013.04.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 85.05 Betriebssoziologie Betriebspsychologie VZ 85.06 Unternehmensführung VZ 89.52 Politische Psychologie Politische Soziologie VZ AR 49 2013 4 16 0716 565-577 13 045F 610 |
| spelling |
10.1016/j.ejps.2013.04.003 doi GBVA2013015000008.pica (DE-627)ELV033288569 (ELSEVIER)S0928-0987(13)00130-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 300 330 360 VZ 85.05 bkl 85.06 bkl 89.52 bkl Salazar, Jaime verfasserin aut Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets 2013 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals Elsevier Müller, Rainer H. oth Möschwitzer, Jan P. oth Enthalten in Elsevier Heyden, Mariano L.M. ELSEVIER The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms 2022 official journal of the European Federation for Pharmaceutical Sciences New York, NY [u.a.] (DE-627)ELV009954198 volume:49 year:2013 number:4 day:16 month:07 pages:565-577 extent:13 https://doi.org/10.1016/j.ejps.2013.04.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 85.05 Betriebssoziologie Betriebspsychologie VZ 85.06 Unternehmensführung VZ 89.52 Politische Psychologie Politische Soziologie VZ AR 49 2013 4 16 0716 565-577 13 045F 610 |
| allfields_unstemmed |
10.1016/j.ejps.2013.04.003 doi GBVA2013015000008.pica (DE-627)ELV033288569 (ELSEVIER)S0928-0987(13)00130-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 300 330 360 VZ 85.05 bkl 85.06 bkl 89.52 bkl Salazar, Jaime verfasserin aut Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets 2013 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals Elsevier Müller, Rainer H. oth Möschwitzer, Jan P. oth Enthalten in Elsevier Heyden, Mariano L.M. ELSEVIER The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms 2022 official journal of the European Federation for Pharmaceutical Sciences New York, NY [u.a.] (DE-627)ELV009954198 volume:49 year:2013 number:4 day:16 month:07 pages:565-577 extent:13 https://doi.org/10.1016/j.ejps.2013.04.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 85.05 Betriebssoziologie Betriebspsychologie VZ 85.06 Unternehmensführung VZ 89.52 Politische Psychologie Politische Soziologie VZ AR 49 2013 4 16 0716 565-577 13 045F 610 |
| allfieldsGer |
10.1016/j.ejps.2013.04.003 doi GBVA2013015000008.pica (DE-627)ELV033288569 (ELSEVIER)S0928-0987(13)00130-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 300 330 360 VZ 85.05 bkl 85.06 bkl 89.52 bkl Salazar, Jaime verfasserin aut Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets 2013 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals Elsevier Müller, Rainer H. oth Möschwitzer, Jan P. oth Enthalten in Elsevier Heyden, Mariano L.M. ELSEVIER The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms 2022 official journal of the European Federation for Pharmaceutical Sciences New York, NY [u.a.] (DE-627)ELV009954198 volume:49 year:2013 number:4 day:16 month:07 pages:565-577 extent:13 https://doi.org/10.1016/j.ejps.2013.04.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 85.05 Betriebssoziologie Betriebspsychologie VZ 85.06 Unternehmensführung VZ 89.52 Politische Psychologie Politische Soziologie VZ AR 49 2013 4 16 0716 565-577 13 045F 610 |
| allfieldsSound |
10.1016/j.ejps.2013.04.003 doi GBVA2013015000008.pica (DE-627)ELV033288569 (ELSEVIER)S0928-0987(13)00130-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 300 330 360 VZ 85.05 bkl 85.06 bkl 89.52 bkl Salazar, Jaime verfasserin aut Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets 2013 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals Elsevier Müller, Rainer H. oth Möschwitzer, Jan P. oth Enthalten in Elsevier Heyden, Mariano L.M. ELSEVIER The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms 2022 official journal of the European Federation for Pharmaceutical Sciences New York, NY [u.a.] (DE-627)ELV009954198 volume:49 year:2013 number:4 day:16 month:07 pages:565-577 extent:13 https://doi.org/10.1016/j.ejps.2013.04.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 85.05 Betriebssoziologie Betriebspsychologie VZ 85.06 Unternehmensführung VZ 89.52 Politische Psychologie Politische Soziologie VZ AR 49 2013 4 16 0716 565-577 13 045F 610 |
| language |
English |
| source |
Enthalten in The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms New York, NY [u.a.] volume:49 year:2013 number:4 day:16 month:07 pages:565-577 extent:13 |
| sourceStr |
Enthalten in The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms New York, NY [u.a.] volume:49 year:2013 number:4 day:16 month:07 pages:565-577 extent:13 |
| format_phy_str_mv |
Article |
| bklname |
Betriebssoziologie Betriebspsychologie Unternehmensführung Politische Psychologie Politische Soziologie |
| institution |
findex.gbv.de |
| topic_facet |
Poorly soluble drugs Particle size reduction High pressure homogenization Spray-drying Tableting Drug nanocrystals |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms |
| authorswithroles_txt_mv |
Salazar, Jaime @@aut@@ Müller, Rainer H. @@oth@@ Möschwitzer, Jan P. @@oth@@ |
| publishDateDaySort_date |
2013-01-16T00:00:00Z |
| hierarchy_top_id |
ELV009954198 |
| dewey-sort |
3610 |
| id |
ELV033288569 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033288569</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623225238.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejps.2013.04.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013015000008.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033288569</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0928-0987(13)00130-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">300</subfield><subfield code="a">330</subfield><subfield code="a">360</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">89.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Salazar, Jaime</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Poorly soluble drugs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Particle size reduction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">High pressure homogenization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Spray-drying</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tableting</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug nanocrystals</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller, Rainer H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Möschwitzer, Jan P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Heyden, Mariano L.M. ELSEVIER</subfield><subfield code="t">The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the European Federation for Pharmaceutical Sciences</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV009954198</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:4</subfield><subfield code="g">day:16</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:565-577</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejps.2013.04.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.05</subfield><subfield code="j">Betriebssoziologie</subfield><subfield code="j">Betriebspsychologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.06</subfield><subfield code="j">Unternehmensführung</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">89.52</subfield><subfield code="j">Politische Psychologie</subfield><subfield code="j">Politische Soziologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">2013</subfield><subfield code="e">4</subfield><subfield code="b">16</subfield><subfield code="c">0716</subfield><subfield code="h">565-577</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Salazar, Jaime |
| spellingShingle |
Salazar, Jaime ddc 610 ddc 300 bkl 85.05 bkl 85.06 bkl 89.52 Elsevier Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets |
| authorStr |
Salazar, Jaime |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009954198 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 300 - Social sciences 330 - Economics 360 - Social problems & services; associations |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 300 330 360 VZ 85.05 bkl 85.06 bkl 89.52 bkl Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals Elsevier |
| topic |
ddc 610 ddc 300 bkl 85.05 bkl 85.06 bkl 89.52 Elsevier Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals |
| topic_unstemmed |
ddc 610 ddc 300 bkl 85.05 bkl 85.06 bkl 89.52 Elsevier Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals |
| topic_browse |
ddc 610 ddc 300 bkl 85.05 bkl 85.06 bkl 89.52 Elsevier Poorly soluble drugs Elsevier Particle size reduction Elsevier High pressure homogenization Elsevier Spray-drying Elsevier Tableting Elsevier Drug nanocrystals |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
r h m rh rhm j p m jp jpm |
| hierarchy_parent_title |
The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms |
| hierarchy_parent_id |
ELV009954198 |
| dewey-tens |
610 - Medicine & health 300 - Social sciences, sociology & anthropology 330 - Economics 360 - Social problems & social services |
| hierarchy_top_title |
The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV009954198 |
| title |
Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets |
| ctrlnum |
(DE-627)ELV033288569 (ELSEVIER)S0928-0987(13)00130-9 |
| title_full |
Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets |
| author_sort |
Salazar, Jaime |
| journal |
The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms |
| journalStr |
The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
565 |
| author_browse |
Salazar, Jaime |
| container_volume |
49 |
| physical |
13 |
| class |
610 610 DE-600 300 330 360 VZ 85.05 bkl 85.06 bkl 89.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Salazar, Jaime |
| doi_str_mv |
10.1016/j.ejps.2013.04.003 |
| dewey-full |
610 300 330 360 |
| title_sort |
application of the combinative particle size reduction technology h 42 to produce fast dissolving glibenclamide tablets |
| title_auth |
Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
4 |
| title_short |
Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets |
| url |
https://doi.org/10.1016/j.ejps.2013.04.003 |
| remote_bool |
true |
| author2 |
Müller, Rainer H. Möschwitzer, Jan P. |
| author2Str |
Müller, Rainer H. Möschwitzer, Jan P. |
| ppnlink |
ELV009954198 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.ejps.2013.04.003 |
| up_date |
2024-07-06T18:12:54.869Z |
| _version_ |
1803854361259933696 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033288569</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623225238.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejps.2013.04.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013015000008.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033288569</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0928-0987(13)00130-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">300</subfield><subfield code="a">330</subfield><subfield code="a">360</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">89.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Salazar, Jaime</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Poorly soluble drugs</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Particle size reduction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">High pressure homogenization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Spray-drying</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tableting</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug nanocrystals</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller, Rainer H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Möschwitzer, Jan P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Heyden, Mariano L.M. ELSEVIER</subfield><subfield code="t">The face of wrongdoing? An expectancy violations perspective on CEO facial characteristics and media coverage of misconducting firms</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the European Federation for Pharmaceutical Sciences</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV009954198</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:4</subfield><subfield code="g">day:16</subfield><subfield code="g">month:07</subfield><subfield code="g">pages:565-577</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejps.2013.04.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.05</subfield><subfield code="j">Betriebssoziologie</subfield><subfield code="j">Betriebspsychologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.06</subfield><subfield code="j">Unternehmensführung</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">89.52</subfield><subfield code="j">Politische Psychologie</subfield><subfield code="j">Politische Soziologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">2013</subfield><subfield code="e">4</subfield><subfield code="b">16</subfield><subfield code="c">0716</subfield><subfield code="h">565-577</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3993816 |